Dr Reddys Labs shares fall 0.87%, trade ex-dividend; stock among top losers on Nifty 50 today
With the stock currently trading among the top losers on the Nifty 50, investors are closely monitoring its performance relative to its historical financials and recent corporate actions.
Alpha Desk
July 10, 2025 / 10:04 IST
DisclaimerThis is an AI-assisted live blog with updates from multiple sourcesDisclaimer
Shares of Dr Reddys Labs were trading lower in Thursday's session. The stock, priced at Rs 1,258.40, experienced a decline of 0.87% on the NSE at 09:30 am. This places it among the top losers on the Nifty 50. Dr Reddy's shares are trading ex-dividend today.
Dr Reddys Labs' financial performance reveals a consolidated revenue of Rs 8,528.40 Crore for the quarter-ending March 2025, compared to Rs 7,113.80 Crore in the quarter-ending March 2024. The net profit for the same period stood at Rs 1,581.20 Crore, up from Rs 1,306.30 Crore.
Financials (Consolidated Quarterly)
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Revenue
Rs 7,113.80 Crore
Rs 7,696.10 Crore
Rs 8,038.20 Crore
Rs 8,381.20 Crore
Rs 8,528.40 Crore
Net Profit
Rs 1,306.30 Crore
Rs 1,386.50 Crore
Rs 1,335.80 Crore
Rs 1,400.00 Crore
Rs 1,581.20 Crore
EPS
78.66
83.61
80.45
16.97
19.12
Analyzing the yearly performance, the consolidated revenue for the year ending March 2025 was Rs 32,643.90 Crore, a notable increase from Rs 28,011.10 Crore in March 2024. The net profit also increased from Rs 5,563.20 Crore to Rs 5,703.50 Crore. Earnings per share (EPS) stood at Rs 67.89 in March 2025, compared to Rs 335.22 in the previous year.
Financials (Consolidated Yearly)
2021
2022
2023
2024
2025
Revenue
Rs 19,047.50 Crore
Rs 21,545.20 Crore
Rs 24,669.70 Crore
Rs 28,011.10 Crore
Rs 32,643.90 Crore
Net Profit
Rs 1,903.60 Crore
Rs 2,112.20 Crore
Rs 4,470.30 Crore
Rs 5,563.20 Crore
Rs 5,703.50 Crore
EPS
117.67
131.57
271.47
335.22
67.89
BVPS
1060.20
1154.59
1397.73
1693.93
402.27
ROE
11.06
11.35
19.35
19.74
16.85
Debt to Equity
0.15
0.16
0.05
0.06
0.12
Income Statement (Consolidated Yearly)
Mar 2025
Mar 2024
Mar 2023
Mar 2022
Mar 2021
Sales
32,643
28,011
24,669
21,545
19,047
Other Income
1,097
894
1,055
484
291
Total Income
33,741
28,905
25,725
22,029
19,338
Total Expenditure
25,800
21,548
19,570
18,942
16,406
EBIT
7,940
7,357
6,154
3,086
2,932
Interest
282
171
142
95
97
Tax
1,954
1,623
1,541
878
931
Net Profit
5,703
5,563
4,470
2,112
1,903
Income Statement (Consolidated Quarterly)
Mar 2025
Dec 2024
Sep 2024
Jun 2024
Mar 2024
Sales
8,528
8,381
8,038
7,696
7,113
Other Income
522
150
307
187
197
Total Income
9,050
8,531
8,345
7,883
7,311
Total Expenditure
6,985
6,579
6,358
5,946
5,650
EBIT
2,065
1,951
1,987
1,936
1,661
Interest
65
81
75
59
59
Tax
418
470
575
490
295
Net Profit
1,581
1,400
1,335
1,386
1,306
Cash Flow (Consolidated Yearly)
Mar 2025
Mar 2024
Mar 2023
Mar 2022
Mar 2021
Operating Activities
4,642
4,543
5,887
2,810
3,570
Investing Activities
-5,807
-4,028
-4,137
-2,638
-2,266
Financing Activities
1,891
-376
-2,686
-242
-29
Others
22
-5
28
73
11
Net Cash Flow
748
132
-907
3
1,285
Balance Sheet (Consolidated Yearly)
Mar 2025
Mar 2024
Mar 2023
Mar 2022
Mar 2021
Share Capital
83
83
83
83
83
Reserves & Surplus
33,466
28,171
23,202
19,129
17,558
Current Liabilities
13,033
9,588
8,572
9,765
8,103
Other Liabilities
2,843
1,021
426
768
871
Total Liabilities
49,426
38,863
32,285
29,746
26,616
Fixed Assets
19,378
11,294
9,701
8,867
9,210
Current Assets
25,018
24,805
20,425
17,782
14,550
Other Assets
5,030
2,763
2,157
3,097
2,855
Total Assets
49,426
38,863
32,285
29,746
26,616
Contingent Liabilities
1,738
2,091
997
936
1,077
Ratios (Consolidated Yearly)
Mar 2025
Mar 2024
Mar 2023
Mar 2022
Mar 2021
Basic EPS (Rs.)
67.89
335.22
271.47
131.57
117.67
Diluted Eps (Rs.)
67.79
334.59
270.90
131.21
117.34
Book Value [Excl. Reval Reserve]/Share (Rs.)
402.27
1,693.93
1,397.73
1,154.59
1,060.20
Dividend/Share (Rs.)
8.00
40.00
40.00
30.00
25.00
Face Value
1
5
5
5
5
Gross Profit Margin (%)
29.54
31.51
30.01
19.73
21.84
Operating Margin (%)
24.32
26.26
24.94
14.32
15.39
Net Profit Margin (%)
17.47
19.86
18.12
9.80
9.99
Return on Networth / Equity (%)
16.85
19.74
19.35
11.35
11.06
ROCE (%)
21.81
25.13
25.95
15.44
15.84
Return On Assets (%)
11.44
14.35
13.96
7.33
7.33
Current Ratio (X)
1.92
2.59
2.38
1.82
1.80
Quick Ratio (X)
1.37
1.92
1.82
1.30
1.24
Debt to Equity (x)
0.12
0.06
0.05
0.16
0.15
Interest Coverage Ratios (X)
34.09
51.59
51.85
44.39
42.90
Asset Turnover Ratio (%)
0.74
0.79
0.80
0.56
0.60
Inventory Turnover Ratio (X)
0.84
0.80
0.85
0.86
1.03
3 Yr CAGR Sales (%)
23.09
21.27
18.67
18.10
15.49
3 Yr CAGR Net Profit (%)
64.32
70.95
50.64
5.26
44.44
P/E (x)
16.85
3.67
3.41
6.53
7.68
P/B (x)
2.84
3.63
3.31
3.73
4.26
EV/EBITDA (x)
10.11
11.62
10.32
17.01
18.20
P/S (x)
2.92
3.67
3.12
3.33
3.94
As of July 10, 2025, the company has announced a final dividend of Rs 8.00 per share, with the ex-date being July 10, 2025. The company had also split its shares, changing the face value from Rs 5 to Rs 1, with the ex-date as October 28, 2024.
With the stock currently trading among the top losers on the Nifty 50, investors are closely monitoring its performance relative to its historical financials and recent corporate actions.
